HCID 18373517, compound → HCID 18373498, compound

HRID 2301564Notes

Reaction equation

HRID 2301564 reaction equation
[Cl:1][C:2]1[C:7]([S:8]([N:11]2[CH2:16][CH2:15][S:14][CH2:13][CH2:12]2)(=[O:10])=[O:9])=[C:6]([OH:17])[C:5]([N+:18]([O-])=O)=[CH:4][CH:3]=1.[H][H]>[Pd]>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([NH2:18])=[C:6]([OH:17])[C:7]=1[S:8]([N:11]1[CH2:16][CH2:15][S:14][CH2:13][CH2:12]1)(=[O:9])=[O:10]

Participants

4

Reactant 2

HCID 18373517HCID 18373517, compoundHCID 178418361HCID 178418361, compound

Product 1

HCID 18373498HCID 18373498, compoundYield 80.1%

Reagents, catalysts & solvents 1

HCID 23938PalladiumCatalyst

Procedure

Following the general hydrogenation procedure outlined in example 15, 6-chloro-2-hydroxy-3-nitro-1-(4-thiomorpholinylsufonyl)benzene (330 mg, 0.97 mmol) was reduced with hydrogen and 10% Pd/C (150 mg) to form the desired product (240 mg, 80%). 1H NMR (MeOD-d4): δ 7.08 (d, 1H), 6.98(d, 1H), 3.59 (t, 4H), 2.68 (t, 4H).

Sources & evidence

ORD record
ord-312d5c242115426d846a907d3403063d
Source dataset
uspto-grants-2002_12
Patent number
US06500863B1

Reaction notes

Loading…